These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
405 related articles for article (PubMed ID: 29779928)
1. The diagnosis and clinical management of the catastrophic antiphospholipid syndrome: A comprehensive review. Cervera R; Rodríguez-Pintó I; Espinosa G J Autoimmun; 2018 Aug; 92():1-11. PubMed ID: 29779928 [TBL] [Abstract][Full Text] [Related]
2. Catastrophic antiphospholipid syndrome: Lessons from 14 cases successfully treated in a single center. A narrative report. Ruffatti A; De Silvestro G; Marson P; Tonello M; Calligaro A; Favaro M; Del Ross T; Hoxha A; Mattia E; Pengo V J Autoimmun; 2018 Sep; 93():124-130. PubMed ID: 30146007 [TBL] [Abstract][Full Text] [Related]
3. Aortitis in the setting of catastrophic antiphospholipid syndrome in a patient with systemic lupus erythematosus. González-García A; López-Rodríguez M; Redondo S; Patier JL; Masso P; Tenorio M; Fajardo GS; Sarhane Y; Lacalzada MM; Manzano L Lupus; 2020 Aug; 29(9):1126-1129. PubMed ID: 32517572 [TBL] [Abstract][Full Text] [Related]
9. [Case series and clinical analysis of 14 cases of catastrophic antiphospholipid syndrome]. Gu JY; Lu C; Shi H; Yang CD Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):1033-1038. PubMed ID: 30562777 [TBL] [Abstract][Full Text] [Related]
10. Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximab. Berman H; Rodríguez-Pintó I; Cervera R; Morel N; Costedoat-Chalumeau N; Erkan D; Shoenfeld Y; Espinosa G; Autoimmun Rev; 2013 Sep; 12(11):1085-90. PubMed ID: 23777822 [TBL] [Abstract][Full Text] [Related]
11. Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the "CAPS Registry". Cervera R; Bucciarelli S; Plasín MA; Gómez-Puerta JA; Plaza J; Pons-Estel G; Shoenfeld Y; Ingelmo M; Espinos G; J Autoimmun; 2009; 32(3-4):240-5. PubMed ID: 19324520 [TBL] [Abstract][Full Text] [Related]
16. Management of refractory cases of catastrophic antiphospholipid syndrome. Espinosa G; Berman H; Cervera R Autoimmun Rev; 2011 Sep; 10(11):664-8. PubMed ID: 21569863 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic and prognostic considerations in catastrophic antiphospholipid syndrome. Erkan D Autoimmun Rev; 2006 Dec; 6(2):98-103. PubMed ID: 17138252 [TBL] [Abstract][Full Text] [Related]
18. Catastrophic antiphospholipid syndrome: treatment, prognosis, and the risk of relapse. Bucciarelli S; Erkan D; Espinosa G; Cervera R Clin Rev Allergy Immunol; 2009 Jun; 36(2-3):80-4. PubMed ID: 19051065 [TBL] [Abstract][Full Text] [Related]
19. Catastrophic antiphospholipid antibody syndrome in systemic lupus erythematosus: an autopsy case report of a young woman. Mizuno R; Fujimoto S; Fujimoto T; Nishino T; Shiiki H; Hashimoto T; Nakamura S; Dohi K Intern Med; 2000 Oct; 39(10):856-9. PubMed ID: 11030215 [TBL] [Abstract][Full Text] [Related]
20. The complex treatment including rituximab in the Management of Catastrophic Antiphospholid Syndrome with renal involvement. Rymarz A; Niemczyk S BMC Nephrol; 2018 Jun; 19(1):132. PubMed ID: 29884138 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]